# Persistence and Compliance Among U.S. Patients Receiving Pazopanib or Sunitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: A Retrospective Claims Analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/persistence-and-compliance-among-u-s-patients-receiving-pazopanib-or-sunitinib/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Stacey A. DaCosta Byfield,Jeffrey McPheeters,Tanya Burton,Saurabh Nagar,Michelle D. Hackshaw |
| Citations | 20 |
| DOI | 10.18553/jmcp.2015.21.6.515 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://pmc.ncbi.nlm.nih.gov/articles/PMC10401993/pdf/jmcp-021-06-515.pdf |
| OpenAlex ID | https://openalex.org/W2342120195 |
| PMID | 26011553 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Jeffrey McPheeters](https://scholariq.org/researchers/jeffrey-mcpheeters/)

## Paper journal

- [Journal of Managed Care & Specialty Pharmacy](https://scholariq.org/journals/journal-of-managed-care-and-specialty-pharmacy/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.